Literature DB >> 30355099

Extracellular Vimentin/VWF (von Willebrand Factor) Interaction Contributes to VWF String Formation and Stroke Pathology.

Titilope A Fasipe1,2, Sung-Ha Hong2,3, Qi Da4,2, Christian Valladolid5,2, Matthew T Lahey3, Lisa M Richards6, Andrew K Dunn6, Miguel A Cruz4,2, Sean P Marrelli2,3.   

Abstract

Background and Purpose- VWF (von Willebrand factor) strings mediate spontaneous platelet adhesion in the vascular lumen, which may lead to microthrombi formation and contribute to stroke pathology. However, the mechanism of VWF string attachment at the endothelial surface is unknown. We tested the novel hypothesis that VWF strings are tethered to the endothelial surface through an interaction between extracellular vimentin and the A2 domain of VWF. We further explored the translational value of blocking this interaction in a model of ischemic stroke. Methods- Human endothelial cells and pressurized cerebral arteries were stimulated with histamine to elicit VWF string formation. Recombinant proteins and antibodies were used to block VWF string formation. Mice underwent transient middle cerebral artery occlusion with reperfusion. Just before recanalization, mice were given either vehicle or A2 protein (recombinant VWF A2 domain) to disrupt the vimentin/VWF interaction. Laser speckle contrast imaging was used to monitor cortical perfusion. Results- Pressurized cerebral arteries produced VWF strings following histamine stimulation, which were reduced in arteries from Vim KO (vimentin knockout) mice. VWF string formation was significantly reduced in endothelial cells incubated with A2 protein or antivimentin antibodies. Lastly, A2 protein treatment significantly improved cortical reperfusion after middle cerebral artery occlusion. Conclusions- We provide the first direct evidence of cerebral VWF strings and demonstrate that extracellular vimentin significantly contributes to VWF string formation via A2 domain binding. Lastly, we show that pharmacologically targeting the vimentin/VWF interaction through the A2 domain can promote improved reperfusion after ischemic stroke. Together, these studies demonstrate the critical role of VWF strings in stroke pathology and offer new therapeutic targets for treatment of ischemic stroke.

Entities:  

Keywords:  endothelium; reperfusion; stroke; thrombosis; vimentin; von Willebrand factor

Mesh:

Substances:

Year:  2018        PMID: 30355099      PMCID: PMC6207252          DOI: 10.1161/STROKEAHA.118.022888

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  15 in total

Review 1.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

2.  ADAMTS13-mediated thrombolysis of t-PA-resistant occlusions in ischemic stroke in mice.

Authors:  Frederik Denorme; Friederike Langhauser; Linda Desender; Aline Vandenbulcke; Hanspeter Rottensteiner; Barbara Plaimauer; Olivier François; Tommy Andersson; Hans Deckmyn; Friedrich Scheiflinger; Christoph Kleinschnitz; Karen Vanhoorelbeke; Simon F De Meyer
Journal:  Blood       Date:  2016-02-29       Impact factor: 22.113

3.  Histones stimulate von Willebrand factor release in vitro and in vivo.

Authors:  Fong W Lam; Miguel A Cruz; Kathan Parikh; Rolando E Rumbaut
Journal:  Haematologica       Date:  2016-03-24       Impact factor: 9.941

4.  Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface.

Authors:  Thomas J Podor; Davindra Singh; Paul Chindemi; Denise M Foulon; Robert McKelvie; Jeffrey I Weitz; Richard Austin; Ghislain Boudreau; Richard Davies
Journal:  J Biol Chem       Date:  2001-12-14       Impact factor: 5.157

5.  GpIbα-VWF blockade restores vessel patency by dissolving platelet aggregates formed under very high shear rate in mice.

Authors:  Audrey Le Behot; Maxime Gauberti; Sara Martinez De Lizarrondo; Axel Montagne; Eloïse Lemarchand; Yohann Repesse; Sylvain Guillou; Cécile V Denis; Eric Maubert; Cyrille Orset; Denis Vivien
Journal:  Blood       Date:  2014-02-19       Impact factor: 22.113

6.  ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion.

Authors:  Masayuki Fujioka; Kazuhide Hayakawa; Kenichi Mishima; Ai Kunizawa; Keiichi Irie; Sei Higuchi; Takafumi Nakano; Carl Muroi; Hidetada Fukushima; Mitsuhiko Sugimoto; Fumiaki Banno; Koichi Kokame; Toshiyuki Miyata; Michihiro Fujiwara; Kazuo Okuchi; Kenji Nishio
Journal:  Blood       Date:  2009-11-13       Impact factor: 22.113

7.  Deficiency of von Willebrand factor protects mice from ischemic stroke.

Authors:  Christoph Kleinschnitz; Simon F De Meyer; Tobias Schwarz; Madeleine Austinat; Karen Vanhoorelbeke; Bernhard Nieswandt; Hans Deckmyn; Guido Stoll
Journal:  Blood       Date:  2009-01-30       Impact factor: 22.113

8.  von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke.

Authors:  Bing-Qiao Zhao; Anil K Chauhan; Matthias Canault; Ian S Patten; Janie J Yang; Michael Dockal; Friedrich Scheiflinger; Denisa D Wagner
Journal:  Blood       Date:  2009-08-17       Impact factor: 22.113

9.  ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.

Authors:  Jing-fei Dong; Joel L Moake; Leticia Nolasco; Aubrey Bernardo; Wendy Arceneaux; Corie N Shrimpton; Alicia J Schade; Larry V McIntire; Kazuo Fujikawa; José A López
Journal:  Blood       Date:  2002-07-25       Impact factor: 22.113

10.  Platelet adhesion involves a novel interaction between vimentin and von Willebrand factor under high shear stress.

Authors:  Qi Da; Molly Behymer; Juliana I Correa; K Vinod Vijayan; Miguel A Cruz
Journal:  Blood       Date:  2014-03-18       Impact factor: 22.113

View more
  12 in total

1.  Modulating the rate of fibrin formation and clot structure attenuates microvascular thrombosis in systemic inflammation.

Authors:  Christian Valladolid; Marina Martinez-Vargas; Nitin Sekhar; Fong Lam; Cameron Brown; Timothy Palzkill; Alexander Tischer; Mathew Auton; K Vinod Vijayan; Rolando E Rumbaut; Trung C Nguyen; Miguel A Cruz
Journal:  Blood Adv       Date:  2020-04-14

2.  Extracellular Vimentin as a Target Against SARS-CoV-2 Host Cell Invasion.

Authors:  Łukasz Suprewicz; Maxx Swoger; Sarthak Gupta; Ewelina Piktel; Fitzroy J Byfield; Daniel V Iwamoto; Danielle Germann; Joanna Reszeć; Natalia Marcińczyk; Robert J Carroll; Paul A Janmey; J M Schwarz; Robert Bucki; Alison E Patteson
Journal:  Small       Date:  2021-12-05       Impact factor: 15.153

Review 3.  Diverse activities of von Willebrand factor in traumatic brain injury and associated coagulopathy.

Authors:  Xin Xu; Rosemary Kozar; Jianning Zhang; Jing-Fei Dong
Journal:  J Thromb Haemost       Date:  2020-10-06       Impact factor: 5.824

Review 4.  Links between thrombosis and inflammation in traumatic brain injury.

Authors:  W Brad Hubbard; Jing-Fei Dong; Miguel A Cruz; Rolando E Rumbaut
Journal:  Thromb Res       Date:  2020-11-25       Impact factor: 3.944

5.  A low-cost mouse cage warming system provides improved intra-ischemic and post-ischemic body temperature control - Application for reducing variability in experimental stroke studies.

Authors:  Sung-Ha Hong; Jeong-Ho Hong; Matthew T Lahey; Liang Zhu; Jessica M Stephenson; Sean P Marrelli
Journal:  J Neurosci Methods       Date:  2021-05-28       Impact factor: 2.987

6.  Conformation-dependent blockage of activated VWF improves outcomes of traumatic brain injury in mice.

Authors:  Xin Xu; Chenyu Wang; Yingang Wu; Katie Houck; Tristan Hilton; Ashley Zhou; Xiaoping Wu; Cha Han; Mengchen Yang; Wei Yang; Fu-Dong Shi; Moritz Stolla; Miguel A Cruz; Min Li; Jianning Zhang; Jing-Fei Dong
Journal:  Blood       Date:  2021-01-28       Impact factor: 25.476

7.  Ablation of miR-144 increases vimentin expression and atherosclerotic plaque formation.

Authors:  Quan He; Fangfei Wang; Takashi Honda; Kenneth D Greis; Andrew N Redington
Journal:  Sci Rep       Date:  2020-04-09       Impact factor: 4.379

Review 8.  Vimentin as a Multifaceted Player and Potential Therapeutic Target in Viral Infections.

Authors:  Irene Ramos; Konstantinos Stamatakis; Clara L Oeste; Dolores Pérez-Sala
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

9.  The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patients.

Authors:  Katarina D Kovacevic; Stefan Greisenegger; Agnes Langer; Georg Gelbenegger; Nina Buchtele; Ingrid Pabinger; Karin Petroczi; Shuhao Zhu; James C Gilbert; Bernd Jilma
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

10.  Intranasal Administration of PACAP Is an Efficient Delivery Route to Reduce Infarct Volume and Promote Functional Recovery After Transient and Permanent Middle Cerebral Artery Occlusion.

Authors:  Asma Cherait; Julie Maucotel; Benjamin Lefranc; Jérôme Leprince; David Vaudry
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-20       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.